The greater a company's earnings, the better its position will be to pay dividends. However, Pfizer's adjusted earnings per ...

The first thing that comes to mind when we speak about the S&P 500 is the biggest tech companies, high valuations, and ...

Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very ...

Compared to ABBV, PFE's latest dividend declarations and earnings report reveal growth pressure, high payout ratios, and ...

You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a way of generating ...

Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly.

Pfizer not only beat expectations last quarter, but also boosted its guidance.

Better still, if interest rates drop, as they're generally expected to over the coming year, the interest income you'll get ...

Pfizer currently has a 7% yield, and the company is making important business moves. Bristol Myers Squibb has a 5.6% yield ...

While many of the top income stocks on the market are expensive, some can be had for well under $100 per share. Here are two ...

The bidding war between Pfizer ( PFE) and Novo Nordisk ( NVO) over obesity drug developer Metsera ( MTSR) finally ended over ...

The lawsuit escalates an unusual, high-profile battle between two large pharmaceutical companies over ownership of a coveted developer of obesity drugs.